PortViewPortView
Diffusion Pharmaceuticals logo

Diffusion Pharmaceuticals (DFFN) Stock Analysis

NASDAQHealthcareBiotechnology

$4.40+10.28%
1-year price historyRange $4.20 – $10.68
52-week range$4.40
$4.14$14.37

Track DFFN in your portfolio for free · Portfolio tracker

What Diffusion Pharmaceuticals does

As a biopharmaceutical enterprise, Diffusion Pharmaceuticals Inc. concentrates on pioneering new treatments that bolster the body's efficiency in oxygen distribution. The company's flagship investigational therapy is Trans Sodium Crocetinate, which is formulated to facilitate the spread of oxygen into tissues. This compound is additionally under development for its application in addressing COVID-19. Headquartered in Charlottesville, Virginia, Diffusion Pharmaceuticals Inc. was established in 2001.

Key metrics

Market cap
$8.98M
P/E (TTM)
-0.62
EPS (TTM)
$-7.11
Beta
1.76
Dividend yield
0.00%
Revenue / share
$0.03
50-day avg
$5.06
200-day avg
$7.07
52-week high
$14.37
52-week low
$4.14
CEO
Robert J. Cobuzzi Jr.,

ETFs linked to DFFN

Broad-market and Healthcare sector ETFs an investor holding Diffusion Pharmaceuticals is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how DFFN fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze DFFN in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Diffusion Pharmaceuticals?
Diffusion Pharmaceuticals trades under the ticker DFFN on NASDAQ.
Which exchange is DFFN listed on?
DFFN is listed on NASDAQ.
What sector does Diffusion Pharmaceuticals operate in?
Diffusion Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze DFFN in a portfolio?
PortView shows DFFN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.